Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2374675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.
Medical subject headings
- Blindness
- Ciprofloxacin
- Optic Nerve Diseases